Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Aprepitant 80mg capsules |
BNF code | 0406000ADAAAAAA |
Virtual Therapeutic Moiety | Aprepitant |
Date identifier became valid | 7 Jul 2023 |
Previous product identifier | 409208006 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 6 Jan 2005 |
Previous name | Aprepitant 80mg capsules |
Basis of previous name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | capsule |
Unit dose unit of measure | capsule |
Virtual Product Ingredient | |
---|---|
Ingredient | Aprepitant |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 80.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | capsule.oral |
Dose Form | |
Formulation | Oral capsule |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Aprepitant 80mg capsules (A A H Pharmaceuticals Ltd) | |
Aprepitant 80mg capsules (Accord-UK Ltd) | |
Aprepitant 80mg capsules (Martindale Pharmaceuticals Ltd) | |
Aprepitant 80mg capsules (Zentiva Pharma UK Ltd) | |
Emend 80mg capsules (Merck Sharp & Dohme (UK) Ltd) | |
Virtual Medicinal Product Packs | |
Aprepitant 80mg capsules 2 capsule |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.